NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
(Total Views: 237)
Posted On: 03/23/2020 4:47:23 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼